tomeko

Intellectual disability syndrome due to a DYRK1A point mutation

Just diagnosed with Intellectual disability syndrome due to a DYRK1A point mutation?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Intellectual disability syndrome due to a DYRK1A point mutation, look for clinical trials, and connect with others living with it — all in one place.

Open the full Intellectual disability syndrome due to a DYRK1A point mutation hub →

Overview

Intellectual disability syndrome due to a DYRK1A point mutation is a rare condition. Also known as DYRK1A-related intellectual disability syndrome due to a point mutation. Tomeko brings together the specialists, research, clinical trials, treatments and community for Intellectual disability syndrome due to a DYRK1A point mutation so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:464311 · OMIM 614104 · ICD-10 Q87.8 · GARD 0021926

Find care for Intellectual disability syndrome due to a DYRK1A point mutation

Authoritative references for Intellectual disability syndrome due to a DYRK1A point mutation

Common questions

I was just diagnosed with Intellectual disability syndrome due to a DYRK1A point mutation — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Intellectual disability syndrome due to a DYRK1A point mutation, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Intellectual disability syndrome due to a DYRK1A point mutation?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Intellectual disability syndrome due to a DYRK1A point mutation, filtered to your area.

Are there clinical trials for Intellectual disability syndrome due to a DYRK1A point mutation?

Tomeko shows live, recruiting studies for Intellectual disability syndrome due to a DYRK1A point mutation from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com